Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers

1. J. Y. Park and S. H. Jang, Epidemiology of lung cancer in Korea: Recent trends, Tuberc. Respir. Dis. (Seoul).79 (2016) 58–69; DOI: 10.4046/trd.2016.79.2.58.10.4046/trd.2016.79.2.58482318527064578Search in Google Scholar

2. S. C. Gupta, S. Patchva, W. Koh and B. B. Aggarwal, Discovery of curcumin, a component of golden spice, and its miraculous biological activities, Clin. Exp. Pharmacol. Physiol.39 (2012) 283–299; DOI: 10.1111/j.1440-1681.2011.05648.x.10.1111/j.1440-1681.2011.05648.x328865122118895Search in Google Scholar

3. H. Mahammedi, E. Planchat, M. Pouget, X. Durando, H. Curé, L. Guy, I. Van-Praagh, L. Savareux, M. Atger, M. Bayet-Robert, E. Gadea, C. Abrial, E. Thivat, P. Chollet and J. C. Eymard, The new combination docetaxel, prednisone and curcumin in patients with castration-resistant prostate cancer: A Pilot Phase II Study, Oncology90 (2016) 69–78; DOI: 10.1159/000441148.10.1159/00044114826771576Search in Google Scholar

4. S. C. Gupta, G. Kismali and B. B. Aggarwal, Curcumin, a component of turmeric: from farm to pharmacy, Biofactors39 (2013) 2–13; DOI: 10.1002/biof.1079.10.1002/biof.107923339055Search in Google Scholar

5. D. Perrone, F. Ardito, G. Giannatempo, M. Dioguardi, G. Troiano, L. Lo Russo, L. A. De, L. Laino and L. Lo Muzio, Biological and therapeutic activities, and anticancer properties of curcumin, Exp. Theor. Med.10 (2015) 1615–1623.10.3892/etm.2015.2749466530126640527Search in Google Scholar

6. M. Kanai, Y. Otsuka, K. Otsuka, M. Sato, T. Nishimura, Y. Mori, M. Kawaguchi, E. Hatano, Y. Kodama, S. Matsumoto, Y. Murakami, A. Imaizumi, T. Chiba, J. Nishihira and H. Shibata, A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients, Cancer Chemother. Pharmacol.71 (2013) 1521–1530; DOI: 10.1007/s00280-013-2151-8.10.1007/s00280-013-2151-823543271Search in Google Scholar

7. H. A. Hazzah, R. M. Farid, M. M. Nasra, M. A. El-Massik and O. Y. Abdallah, Lyophilized sponges loaded with curcumin solid lipid nanoparticles for buccal delivery: Development and characterization, Int. J. Pharm.492 (2015) 248–257; DOI: 10.1016/j.ijpharm.2015.06.022.10.1016/j.ijpharm.2015.06.02226189427Search in Google Scholar

8. F. Foglietta, L. Serpe, R. Canaparo, N. Vivenza, G. Riccio, E. Imbalzano, P. Gasco and G. P. Zara, Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines, J. Pharm. Pharm. Sci.17 (2014) 231–247.Search in Google Scholar

9. N. Naseri, H. Valizadeh and P. Zakeri-Milani, Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application, Adv. Pharm. Bull.5 (2015) 305–313; DOI: 10.15171/apb.2015.043.10.15171/apb.2015.043461689326504751Search in Google Scholar

10. R. H. Müller, R. Shegokar and C. M. Keck, 20 years of lipid nanoparticles (SLN and NLC): Present state of development and industrial applications, Curr. Drug. Discov. Technol.8 (2011) 207–227.10.2174/15701631179679906221291409Search in Google Scholar

11. S. Selvamuthukumar and R. Velmurugan, Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy, Lipids Health Dis.11 (2012) 159; DOI: 10.1186/1476-511X-11-159.10.1186/1476-511X-11-159356122523167765Search in Google Scholar

12. J. Chen, W. T. Dai, Z. M. He, L. Gao, X. Huang, J. M. Gong, H.Y. Xing and W. D. Chen, Fabrication and Evaluation of Curcumin-loaded Nanoparticles Based on Solid Lipid as a New Type of Colloidal Drug Delivery System, Indian J. Pharm. Sci.75 (2013) 178–184.Search in Google Scholar

13. W. H. Lee, C. Y. Loo, P. M. Young, D. Traini, R. S. Mason and R. Rohanizadeh, Recent advances in curcumin nanoformulation for cancer therapy, Expert Opin. Drug Deliv.11 (2014) 1183–1201; DOI: 10.1517/17425247.2014.916686.10.1517/17425247.2014.91668624857605Search in Google Scholar

14. Q. Y. Chen, Y. Zheng, D. M. Jiao, F.Y. Chen, H. Z. Hu, Y. Q. Wu, J. Song, J. Yan, L. J. Wu and G. Y. Lv, Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway, J. Nutr. Biochem.25 (2014) 177–185; DOI: 10.1016/j.jnutbio.2013.10.004.10.1016/j.jnutbio.2013.10.00424445042Search in Google Scholar

15. M. Cao, L. Ren and G. Chen, Formulation optimization and ex vivo and in vivo evaluation of celecoxib microemulsion-based gel for transdermal delivery, AAPS PharmSciTech. (2016) Dec 2. [Epub ahead of print].10.1208/s12249-016-0667-z27914040Search in Google Scholar

16. C. Hasovits and S. Clarke, Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics, Clin. Pharmacokinet.51 (2012) 203–224; DOI: 10.2165/11598890-000000000-00000.10.2165/11598890-000000000-0000022420577Search in Google Scholar

17. S. K. Williamson, G. A. Johnson, H. A. Maulhardt, K. M. Moore, D. S. McMeekin, T. K. Schulz, G. A. Reed, K. F. Roby, C. B. Mackay, H. J. Smith, S. J. Weir, J. A. Wick, M. Markman, G. S. diZerega, M. J. Baltezor, J. Espinosa and C. J. Decedue, A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax^®) in patients with peritoneal malignancies, Cancer Chemother. Pharmacol.75 (2015) 1075–1087; DOI: 10.1007/s00280-015-2737-4.10.1007/s00280-015-2737-4450613125898813Search in Google Scholar

18. P. Maincent, P. Thouvenot, C. Amicabile, M. Hoffman, J. Kreuter, P. Couvreur and J. P. Devissaguet, Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats, Pharm. Res.9 (1992) 1534–1539.10.1023/A:1015895804597Search in Google Scholar

19. S. Kommareddy, S. B. Tiwari and M. M. Amiji, Long-circulatin polymeric nanovectors for tumorselective gene delivery, Technol. Cancer Res. Treat.4 (2005) 615–625.10.1177/15330346050040060516292881Search in Google Scholar

20. R. Tiwari and K. Pathak, Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake, Int. J. Pharm.415 (2011) 232–243; DOI: 10.1016/j.ijpharm.2011.05.044.10.1016/j.ijpharm.2011.05.04421640809Search in Google Scholar

21. M. Fang, Y. Jin, W. Bao, H. Gao, M. Xu, D. Wang, X. Wang, P. Yao and L. Liu, In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration, Int. J. Nanomedicine7 (2012) 5395–5404; DOI: 10.2147/IJN.S36257.10.2147/IJN.S36257347160423091382Search in Google Scholar

22. D. Zheng, W. Dai, D. Zhang, C. Duan, L. Jia, Y. Liu and Q. Zhang, In vivo studies on the oridonin-loaded nanostructured lipid carriers, Drug Deliv.19 (2012) 286–291; DOI: 10.3109/10717544.2012.704096.10.3109/10717544.2012.70409622928767Search in Google Scholar

23. C. Mohanty and S. K. Sahoo, The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation, Biomaterials31 (2012) 6597–6611. DOI: 10.1016/j.biomaterials.2010.04.062.10.1016/j.biomaterials.2010.04.06220553984Search in Google Scholar

24. H. Rosen and T. Abribat, The rise and rise of drug delivery, Nat. Rev. Drug Discov.4 (2005) 381–385.10.1038/nrd172115864267Search in Google Scholar

25. D. Breznan, D. D. Das, J. S. O’Brien, C. MacKinnon-Roy, S. Nimesh, N. Q. Vuong, S. Bernatchez, N. DeSilva, Hill M, P. Kumarathasan, R. Vincent, Differential cytotoxic and inflammatory potency of amorphous silicon dioxide nanoparticles of similar size in multiple cell lines, Nanotoxicology. 1 (2017) 1–45. DOI: 10.1080/17435390.2017.1287313.10.1080/17435390.2017.128731328142331Search in Google Scholar

26. J. H. Duan, Y. D. Zhang, S. W. Han, Y. X. Chen, B. Li, M. M. Liao, W. Chen, X. M. Deng, J. F. Zhao and B. Y. Huang, Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles, Int. J. Pharm.400 (2010) 211–220.10.1016/j.ijpharm.2010.08.03320813175Search in Google Scholar

27. S. Lev-Ari, L. Strier, D. Kazanov, O. Elkayam, D. Lichtenberg, D. Caspi and N. Arber, Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells, Rheumatology (Oxford)45 (2006) 171–177.10.1093/rheumatology/kei13216249246Search in Google Scholar

28. S. Lev-Ari, A. Vexler, A. Starr, M. Ashkenazy-Voghera, J. Greif, D. Aderka and R. Ben-Yosef, Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines, Cancer Invest.25 (2007) 411–418.10.1080/0735790070135957717882652Search in Google Scholar